Science Explorer Back to mapMap

Most cited papers from Agenta Biotechnologies (United States)

Agenta Biotechnologies (United States)

What are the most cited papers from Agenta Biotechnologies (United States)?

The most cited paper from Agenta Biotechnologies (United States) is "Intracellular survival and vascular cell-to-cell transmission of Porphyromonas gingivalis" (Ling Li, Raynald Michel, Joshua Cohen et al., 2008), with 114 citations. Next come "Perlecan and vascular endothelial growth factor-encoding DNA-loaded chitosan scaffolds promote angiogenesis and wound healing" (79) and "Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer" (52).

Showing 10 of 10 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Intracellular survival and vascular cell-to-cell transmission of Porphyromonas gingivalis Ling Li, Raynald Michel, Joshua Cohen et al. · BMC Microbiology Open access 6 Feb 2008 114
2 Perlecan and vascular endothelial growth factor-encoding DNA-loaded chitosan scaffolds promote angiogenesis and wound healing Megan Susan Lord, April L. Ellis, Brooke L. Farrugia et al. · Journal of Controlled Release Open access 9 Feb 2017 79
3 Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer Stephen Kalscheuer, Vidhi Khanna, Hyunjoon Kim et al. · Scientific Reports Open access 28 Aug 2019 52
4 Perlecan domain 1 recombinant proteoglycan augments BMP-2 activity and osteogenesis Arthur A. DeCarlo, Maria E. Belousova, April L. Ellis et al. · BMC Biotechnology Open access 11 Sep 2012 36
5 Feasibility of an HA2 Domain-Based Periodontitis Vaccine Arthur A. DeCarlo, Yi‐Fang Huang, Charles A. Collyer et al. · Infection and Immunity Open access 20 Dec 2002 31
6 Blockade of protease-activated receptors on T cells correlates with altered proteolysis of CD27 by gingipains ofPorphyromonas gingivalis L W P Yun, Arthur A. DeCarlo, Neil Hunter · Clinical & Experimental Immunology Open access 23 Aug 2007 30
7 The Role of Heparan Sulfate and Perlecan in Bone-regenerative Procedures Arthur A. DeCarlo, John Michael Whitelock · Journal of Dental Research Feb 2006 21
8 Dense chitosan surgical membranes produced by a coincident compression-dehydration process Thomas P. Dooley, April L. Ellis, Maria E. Belousova et al. · Journal of Biomaterials Science Polymer Edition Open access 13 Aug 2012 11
9 Similarity of Recombinant Human Perlecan Domain 1 by Alternative Expression Systems Bioactive Heterogenous Recombinant Human Perlecan D1 April L. Ellis, Wensheng Pan, Guang Yang et al. · BMC Biotechnology Open access 9 Sep 2010 11
10 Low Intrinsic Killing Activity and no Impact of Its Positivity on Phase 3 Pneumococcal Vaccine Adult Studies Weifeng Xu, Joseph M. Antonello, Jennifer L. Nguyen et al. · The Journal of Infectious Diseases 8 Aug 2025 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.